Abstract
BackgroundRecipients of haematopoietic stem cells are at high risk of developing invasive fungal disease (IFD) which is the leading cause of morbidity and mortality in these immunocompromised patients.Fluconazole and voriconazole...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
